Skip to main content

Table 2 Receiver operating characteristics curve (ROC) analysis using tissue and plasma miRNAs expression for discriminating endometrioid endometrial cancer (EEC) samples

From: Deregulation of miR-100, miR-99a and miR-199b in tissues and plasma coexists with increased expression of mTOR kinase in endometrioid endometrial carcinoma

miRNA/miRNA signature

AUC [95% CI]

p

Sensitivity

Specificity

C

+PV

-PV

Tissues (EEC n = 73, NE  n= 31)

miR-99a

0.675 [0.572-0.767]

0.006

0.88

0.5

6.6

81.3

63.6

miR-100

0.652 [0.548-0.746]

0.03

0.86

0.5

6.5

80.8

58.3

miR-199b

0.706 [0.606-0.794]

0.001

0.81

0.71

5.3

87.5

60.6

miR-99a/miR-100/miR-199b

0.774 [0.678-0.853]

<0.0001

0.61

0.89

0.76

93.3

48.1

Plasma (EEC n = 34, NE n = 14)

miR-99a

0.810 [0.669-0.909]

<0.0001

0.76

0.79

1.23

89.3

57.9

miR-100

0.740 [0.592-0.857]

0.001

0.64

0.79

1.5

33.3

92.8

miR-199b

0.786 [0.642-0.892]

0.0002

0.79

0.71

2.48

86.7

58.8

miR-99a/miR-199b

0.903 [0.780-0.970]

<0.0001

0.88

0.93

0.73

96.7

76.5

  1. AUC - area under curve; 95% CI – 95% confidence interval; C - factor; +PV - positive predictive value; -PV - negative predictive value.